Doxycycline prophylaxis and gonococcal resistance: reassurance, residual signals, and the case for surveillance
Authors:
- 2 July 2026
- journal article
- Published by Elsevier in Clinical Microbiology and Infection
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance to doxycycline and ceftriaxone in Milan, ItalyClinical Microbiology and Infection, 2026
- WHO global gonococcal antimicrobial surveillance programmes, 2019–22: a retrospective observational studyThe Lancet Microbe, 2025
- Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial designThe Lancet Infectious Diseases, 2024
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted InfectionsNew England Journal of Medicine, 2023
- The impact of antimicrobials on gonococcal evolutionNature Microbiology, 2019